General Information
Revision date
2009-05-20
Product name
DURASYN 128 POLYALPHAOLEFIN
supplier name
INEOS USA LLC
Icons in SDS
Company Information
company name
INEOS USA LLC
e-mail address of the competent person responsible for the Safety Data Sheet
OLIGOMERSMSDS@ineos.com
Section 2
SECTION 2: Hazards identification
Physical state Liquid. Odor : Odorless. OSHA/HCS status : While this material is not considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200), this MSDS contains valuable information critical to the safe handling and proper use of the product. This MSDS should be retained and available for employees and other users of this product. Emergency overview NOT EXPECTED TO PRODUCE SIGNIFICANT ADVERSE HEALTH EFFECTS WHEN THE RECOMMENDED INSTRUCTIONS FOR USE ARE FOLLOWED. No known significant effects or critical hazards. Avoid prolonged contact with eyes, skin and clothing.
Principle Routes of Exposure
Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Inhalation Inhalation of oil mist or vapors at elevated temperatures may cause respiratory irritation. Ingestion No known significant effects or critical hazards. Skin No known significant effects or critical hazards. Eyes No known significant effects or critical hazards.
Potential chronic health
effects : No known significant effects or critical hazards. Carcinogenicity : No component of this product at levels greater than 0.1% is identified as a carcinogen by ACGIH or the International Agency for Research on Cancer (IARC). No component of this product present at levels greater than 0.1% is identified as a carcinogen by the U.S. National Toxicology Program (NTP) or the U.S. Occupational Safety and Health Act (OSHA). Mutagenicity : No component of this product at levels greater than 0.1% is classified by established regulatory criteria as a mutagen.
Teratogenic Effects
No component of this product at levels greater than 0.1% is classified by established regulatory criteria as teratogenic or embryotoxic. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Over-exposure signs/symptoms Inhalation : No specific data. Ingestion : No specific data. Skin : No specific data. Eyes : No specific data. Medical conditions : None known. aggravated by over- exposure See toxicological information (section 11)
